245 related articles for article (PubMed ID: 6127458)
1. Influence of delta infection on severity of hepatitis B.
Smedile A; Farci P; Verme G; Caredda F; Cargnel A; Caporaso N; Dentico P; Trepo C; Opolon P; Gimson A; Vergani D; Williams R; Rizzetto M
Lancet; 1982 Oct; 2(8305):945-7. PubMed ID: 6127458
[TBL] [Abstract][Full Text] [Related]
2. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
3. Fulminant B viral hepatitis: role of delta agent.
Govindarajan S; Chin KP; Redeker AG; Peters RL
Gastroenterology; 1984 Jun; 86(6):1417-20. PubMed ID: 6714570
[TBL] [Abstract][Full Text] [Related]
4. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.
Farci P; Smedile A; Lavarini C; Piantino P; Crivelli O; Caporaso N; Toti M; Bonino F; Rizzetto M
Gastroenterology; 1983 Sep; 85(3):669-73. PubMed ID: 6873613
[TBL] [Abstract][Full Text] [Related]
5. Fulminant delta hepatitis in chronic hepatitis B infection.
De Cock KM; Govindarajan S; Redeker AG
JAMA; 1984 Nov; 252(19):2746-8. PubMed ID: 6387205
[TBL] [Abstract][Full Text] [Related]
6. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
[TBL] [Abstract][Full Text] [Related]
7. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey.
Saracco G; Macagno S; Rosina F; Rizzetto M
Ann Intern Med; 1988 Mar; 108(3):380-3. PubMed ID: 3341675
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of delta infection in the western Pacific region.
Dimitrakakis M; Crowe S; Gust I
J Med Virol; 1986 Apr; 18(4):335-9. PubMed ID: 3011980
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection.
Smedile A; Lavarini C; Crivelli O; Raimondo G; Fassone M; Rizzetto M
J Med Virol; 1982; 9(2):131-8. PubMed ID: 6175733
[TBL] [Abstract][Full Text] [Related]
11. Acute delta hepatitis without circulating HBsAg.
De Cock KM; Govindarajan S; Redeker AG
Gut; 1985 Feb; 26(2):212-4. PubMed ID: 3967840
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
Rizzetto M; Purcell RH; Gerin JL
Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
[TBL] [Abstract][Full Text] [Related]
13. [Superinfection with delta agent in chronic carriers of HBsAg in Spain. Clinical, epidemiologic and virologic characteristics].
Bas L; Carreño V; Porres JC; Mora I; Gutiez J; de Torres M; Hernández Guio C
Rev Clin Esp; 1984 Oct; 175(2):67-9. PubMed ID: 6522725
[No Abstract] [Full Text] [Related]
14. [Hepatitis B and the delta agent].
Jilg W; Roggendorf M; Zoulek G; Schlipköter U; Deinhardt F
Fortschr Med; 1984 Feb; 102(6):119-21. PubMed ID: 6706267
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects of delta infection.
Moestrup T; Hansson BG; Widell A; Nordenfelt E
Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin.
Bensabath G; Hadler SC; Soares MC; Fields H; Dias LB; Popper H; Maynard JE
JAMA; 1987 Jul 24-31; 258(4):479-83. PubMed ID: 3599343
[TBL] [Abstract][Full Text] [Related]
17. A possible misdiagnosis in patients presenting with acute HBsAg-negative hepatitis: the role of hepatitis delta virus.
Caredda F; Antinori S; Pastecchia C; Coppin P; Arici C; Fracassetti O
Infection; 1988; 16(6):358-9. PubMed ID: 3220581
[TBL] [Abstract][Full Text] [Related]
18. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
Burkhardt F; Schilt U
Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
[TBL] [Abstract][Full Text] [Related]
19. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
20. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
Rosina F; Saracco G; Rizzetto M
N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
